Maryland TEDCO — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Co-investorsBioAdvanceBioGenerator VenturesNYBC VenturesOld Line Capital PartnersTEDCO
LifeSprout develops synthetic materials that mimic the body's own tissues for aesthetic and regenerative medicine, creating products to treat patients with soft tissue loss from aging, cancer, and metabolic disease.
BiotechMedical DevicesNew MaterialsBaltimore, US
Hai-Quan Mao(Co-founder, PhD)Sashank Reddy(Co-founder, MD, PhD)Kevin Colbert(Co-founder, Business Development)inRuss Martin(Co-founder, Head of R&D, PhD)inAdam Gridley(Executive Chairman, MBA)
BoardGregory Sieczkiewicz(Executive Officer, Director, Promoter)
Co-investorsCatalio Capital Management, LPEmerald Development ManagersTEDCO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.